Valuation : PAVmed Inc.

Market Cap 36.43M 31.43M 29.57M 26.96M 50.62M 3.46B 50.97M 350M 136M 1.76B 137M 134M 5.84B P/E 2026 *
-1.44x
P/E 2027 * -2.63x
Enterprise Value 36.43M 31.43M 29.57M 26.96M 50.62M 3.46B 50.97M 350M 136M 1.76B 137M 134M 5.84B EV / Sales 2026 *
157x
EV / Sales 2027 * 60.7x
Free-Float
58.56%
Yield 2026 *
-
Yield 2027 * -
1 day-4.22%
1 week-2.16%
Current month-4.22%
1 month+0.81%
3 months-19.49%
6 months-50.50%
Current year-24.67%
1 week 4.9
Extreme 4.9
5.6
1 month 4.19
Extreme 4.19
5.6
Current year 3.85
Extreme 3.85
28.44
1 year 3.85
Extreme 3.85
28.44
3 years 3.85
Extreme 3.85
270
5 years 3.85
Extreme 3.85
4,365
10 years 3.85
Extreme 3.85
6,502.5
Manager TitleAgeSince
Compliance Officer 62 31/03/2023
Chief Executive Officer 60 25/06/2014
Director of Finance/CFO 68 28/02/2019
Director TitleAgeSince
Director/Board Member 60 30/09/2014
Chairman 60 25/06/2014
Director/Board Member 71 31/12/2014
Date Insider Type Main position Quantity % Market Cap. Importance
02/04/26 Free

Chief Technology Officer

70,000 1.0966%
02/04/26 Free

Chief Operating Officer

110,000 1.7233%
02/04/26 Free

Chief Executive Officer

350,000 5.4832%
Change 5-day change 1-year change 3-year change Capi.($)
-4.22%-2.16%-65.71%-96.46% 36.43M
-2.69%-4.49%+21.87%+7.79% 228B
-3.10%-3.80%+0.54%-21.91% 150B
-2.02%-1.16%-21.98%+18.09% 133B
-0.46%-1.90%-54.43%-10.86% 70B
-0.01%+0.27%+11.56%+18.66% 52.31B
+0.43%-2.70%-16.93%-15.03% 50.59B
-2.36%-2.28%+19.31%+23.84% 43.3B
-2.12%-1.20%+34.47%+44.53% 40.74B
-3.64%-0.47%-15.72%+44.97% 34.63B
Average -1.74%-0.46%-8.70%+1.36% 80.3B
Weighted average by Cap. -1.62%-1.02%-0.28%+5.92%

Financials

2026 *2027 *
Net sales 232K 201K 189K 172K 323K 22.07M 325K 2.24M 868K 11.22M 873K 854K 37.24M 600K 518K 487K 444K 834K 56.96M 839K 5.77M 2.24M 28.96M 2.25M 2.2M 96.12M
Net income -23.17M -19.99M -18.81M -17.15M -32.2M -2.2B -32.42M -223M -86.54M -1.12B -87M -85.11M -3.71B -20.15M -17.38M -16.35M -14.91M -28M -1.91B -28.19M -194M -75.24M -973M -75.65M -74M -3.23B
Net Debt - -
Logo PAVmed Inc.
PAVmed Inc. is a multi-product, commercial-stage medical technology company. The Company operates in the medical devices, diagnostics, and digital health sectors. Its subsidiary includes Lucid Diagnostics Inc., which is a commercial-stage cancer prevention medical diagnostics company that markets the EsoGuard Esophageal DNA Test and EsoCheck Esophageal Cell Collection Device for early detection of esophageal precancer to prevent esophageal cancer deaths. EsoCheck is a noninvasive swallowable balloon capsule catheter device capable of sampling surface esophageal cells. EsoGuard is a bisulfite-converted next-generation sequencing (NGS) DNA assay performed on surface esophageal cells collected with EsoCheck. Its other subsidiary, Veris Health Inc., is a digital health company focused on enhanced personalized cancer care through remote patient monitoring using implantable biologic sensors with wireless communication along with a custom suite of connected external devices.
Employees
41
Date Price Change Volume
01/09/26 US$4.990 -4.22% 4,211
31/08/26 US$5.210 +5.89% 31,436
28/08/26 US$4.920 -2.96% 10,355
27/08/26 US$5.070 -4.70% 11,178
26/08/26 US$5.320 +0.85% 1,216
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
5.210USD
Average target price
36.50USD
Spread / Average Target
+600.58%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. PAVM Stock